Life Technologies, Febit Ink Co-marketing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies and Febit jointly announced today that they have signed a co-marketing deal, under which the firms will offer Febit's HybSelect sequence capture technology with Life Tech's SOLiD sequencing system.

The firms said that the alliance is aimed at researchers conducting targeted resequencing studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.